Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly-diagnosed Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04953780
What this trial is testing

Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia
West Virginia University 6
Testing effectiveness (Phase 2)WithdrawnNCT06858501
What this trial is testing

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaGanglioneuroblastoma, NodularHigh Risk Neuroblastoma
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01977677
What this trial is testing

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Who this might be right for
Adult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more
Lawrence Recht 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06477939
What this trial is testing

Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients

Who this might be right for
Glioblastoma
Institut de cancérologie Strasbourg Europe 554
Large-scale testing (Phase 3)Active Not RecruitingNCT02466971
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Who this might be right for
Advanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 450
Large-scale testing (Phase 3)Looking for participantsNCT05331521
What this trial is testing

A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).

Who this might be right for
Oligodendroglioma
University Hospital Heidelberg 406
Testing effectiveness (Phase 2)Looking for participantsNCT05389293
What this trial is testing

Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Who this might be right for
Follicular LymphomaLymphoma
Memorial Sloan Kettering Cancer Center 152
Testing effectiveness (Phase 2)Looking for participantsNCT06796998
What this trial is testing

Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

Who this might be right for
Marginal Zone LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueSplenic Marginal Zone Lymphoma+1 more
Izidore Lossos, MD 25
Testing effectiveness (Phase 2)UnknownNCT05147493
What this trial is testing

Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal ImpairmentNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 51
Not applicableStudy completedNCT04774744
What this trial is testing

Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 157
Not applicableLooking for participantsNCT06533163
What this trial is testing

Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial

Who this might be right for
Glioblastoma Multiforme
BioTex, Inc. 30
Not applicableNo Longer AvailableNCT03114228
What this trial is testing

An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)

Who this might be right for
FLT3-mutated Acute Myeloid Leukemia
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Looking for participantsNCT06345365
What this trial is testing

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukaemia
Zhongnan Hospital 154
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07664839
What this trial is testing

Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations

Who this might be right for
Acute Myeloid LeukemiaNPM1 MutationIDH1 Mutation+1 more
Shen yang 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT05681039
What this trial is testing

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Who this might be right for
Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
M.D. Anderson Cancer Center 29
Large-scale testing (Phase 3)Study completedNCT02112175
What this trial is testing

Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM

Who this might be right for
Multiple Myeloma
Celgene 46
Not applicableStudy completedNCT02439112
What this trial is testing

Exercise in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Zealand University Hospital 102
Large-scale testing (Phase 3)Ended earlyNCT00984828
What this trial is testing

Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Shanghai Jiao Tong University School of Medicine 23
Post-approval studies (Phase 4)Study completedNCT04217967
What this trial is testing

Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients

Who this might be right for
Multiple Myeloma
Peking Union Medical College Hospital 211
Testing effectiveness (Phase 2)Study completedNCT00003311
What this trial is testing

Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 19
Next Page